Valuation: Optiscan Imaging Limited

Market Cap 125M 88.46M 76.68M 71.88M 65.54M 123M 8.44B 846M 330M 4.23B 332M 325M 14.1B P/E 2024
-31.8x
P/E 2025 -14.5x
Enterprise Value 122M 86.3M 74.8M 70.12M 63.94M 120M 8.24B 826M 322M 4.12B 324M 317M 13.75B EV / Sales 2024
62.1x
EV / Sales 2025 23.8x
Free-Float
36.32%
Yield 2024 *
-
Yield 2025 -
1 day-2.70%
1 week+12.50%
Current month+24.14%
1 month+16.13%
3 months+63.64%
6 months+100.00%
Current year+80.00%
1 week 0.16
Extreme 0.162
0.2
1 month 0.14
Extreme 0.14
0.2
Current year 0.08
Extreme 0.08
0.2
1 year 0.08
Extreme 0.079
0.2
3 years 0.07
Extreme 0.071
0.26
5 years 0.07
Extreme 0.071
0.29
10 years 0.01
Extreme 0.013
0.47
Manager TitleAgeSince
Chief Executive Officer - 2021-12-12
Director of Finance/CFO - 2025-03-30
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member - 2021-02-09
Chairman - 2021-04-18
Director/Board Member - 2021-05-05
Date Insider Type Main position Quantity % Market Cap.
1/15/26 Free

Director

230,502 0.0221%
1/15/26 Free

Chairman

419,094 0.0401%
1/15/26 Free

Chief Executive Officer

6,157,719 0.5897%
Change 5-day change 1-year change 3-year change Capi.($)
-2.70%+12.50%+104.55%+136.84% 137M
-1.10%-3.22%-16.68%-18.03% 13.44B
+3.51%+8.64%+39.80%+8.67% 4.39B
+0.39%+1.02%-39.65%-50.95% 1.31B
-0.69%-2.38%-35.63%-38.92% 1.21B
+10.99%+34.65%-28.19% - 1.17B
-0.27%-5.12%+19.40%+83.22% 1.12B
-7.01%+8.95%+48.97%+145.48% 636M
-1.02%+0.30%+67.24% - 343M
+2.33%+2.63%-59.97%+277.61% 257M
Average +0.44%+4.22%+9.98%+67.99% 2.4B
Weighted average by Cap. +0.34%+0.18%-4.26%-1.88%

Financials

2024 2025
Net sales 2.99M 2.11M 1.83M 1.71M 1.56M 2.94M 201M 20.17M 7.87M 101M 7.91M 7.74M 336M 3.72M 2.63M 2.28M 2.14M 1.95M 3.67M 251M 25.16M 9.82M 126M 9.87M 9.66M 419M
Net income -6.06M -4.28M -3.71M -3.48M -3.17M -5.96M -408M -40.94M -15.98M -204M -16.06M -15.72M -682M -6.31M -4.46M -3.86M -3.62M -3.3M -6.21M -425M -42.64M -16.65M -213M -16.73M -16.37M -710M
Net Debt -11.01M -7.77M -6.74M -6.32M -5.76M -10.84M -742M -74.38M -29.04M -371M -29.19M -28.55M -1.24B -3.07M -2.17M -1.88M -1.76M -1.61M -3.02M -207M -20.74M -8.1M -104M -8.14M -7.96M -346M
Logo Optiscan Imaging Limited
Optiscan Imaging Limited is a commercial stage medical technology company. It creates a suite of digital pathology and precision surgery hardware and software solutions that enable live optical biopsy for life sciences, diagnostic and surgical applications. It is engaged in development, manufacturing, and commercialization of confocal endomicroscopic imaging technologies for medical, translational and pre-clinical applications. Its technology enables real-time, non-destructive, 3D, in-vivo digital imaging at the single-cell level. Its products include InVue, InForm, InVivage, ViewnVivo and InSpecta. ViewnVivo offers single-cell level live imaging, providing biological system insights and enabling users to see life connected. Developed with its patented confocal imaging technology, ViewnVivo is a miniaturized in vivo imaging device that offers single-cell 3D live microscopic imaging in the palm of your hand. InVivage is an intra-oral digital endomicroscope.
Employees
9
Date Price Change Volume
26-08-13 A$0.1800 -2.70% 319,681
26-08-12 A$0.1850 -5.13% 297,276
26-08-11 A$0.1950 +5.41% 833,531
26-08-10 A$0.1850 +8.82% 745,156
26-08-07 A$0.1700 +6.25% 160,906